Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-16-023361)

Filing Details

Accession Number:: 0001179110-16-023361
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2016-04-27 17:21:49
Reporting Period:: 2015-01-16

Filing Date:: 2016-04-27
Accepted Time:: 2016-04-27 17:21:49
Original Submission Date:: 2015-01-20
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1145460	Alere Inc.	ALR	In Vitro & In Vivo Diagnostic Substances (2835)	043565120

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1600843	Carla Flakne	51 Sawyer Road, Suite 200 Waltham MA 02453	Vp, Chief Accounting Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-01-16	10,000	$42.45	3,714	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

This amendment is being filed solely to reflect an additional 462 shares of Alere common stock as being directly held by the reporting person. The reporting person's original Form 4 erroneously reported these shares as being held indirectly by the 2012 Flakne Family Trust, of which the reporting person is a trustee.